The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 14, 2023

Filed:

Jun. 01, 2018
Applicant:

Affymetrix, Inc., Carlsbad, CA (US);

Inventors:

Ronald Sapolsky, Palo Alto, CA (US);

Michael Shapero, Campbell, CA (US);

Jeanette Schmidt, Palo Alto, CA (US);

Eric Fung, Los Altos, CA (US);

Orna Mizrahi Man, Amirim, IL;

Jiang Li, Fremont, CA (US);

Monica Chadha, Fremont, CA (US);

Anju Shukla, San Jose, CA (US);

Assignee:

Affymetrix, Inc., Carlsbad, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6837 (2018.01); C12Q 1/6827 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6837 (2013.01); C12Q 1/6827 (2013.01); C12Q 2535/131 (2013.01); C12Q 2537/125 (2013.01); C12Q 2537/143 (2013.01);
Abstract

This disclosure provides methods and systems useful in array-based analysis of mixed nucleic acid populations, including for multiplex genotyping of a mixed nucleic acid sample and for detecting differences in copy number of a target polynucleotide and/or a target chromosome (e.g., microdeletions, duplications and aneuploidies). The disclosure also provides methods and systems useful in the diagnosis of genetic abnormalities in a mixed nucleic acid population taken non-invasively from an organism, such as a sample of blood, plasma, serum, urine stool or saliva. The disclosed methods and systems find use in multiple applications, including prenatal testing and cancer diagnostics. The disclosure is based on the hybridisation of amplified fragments from the sample, e.g. a maternal sample, which may employ molecular inversion probes MIP to an oligonucleotide array and the detection of the alleles based on different signals from the different alleles of the SNP. The disclosure also discloses how the determination of the allele ratio may be used in the determination of fetal and maternal CNVs, e.g. aneuploidies.


Find Patent Forward Citations

Loading…